How Many Doses Per Vial of Pinealon? (Reconstitution Guide)

A standard 10mg Pinealon vial doesn't contain a predetermined number of doses. The yield depends entirely on your reconstitution volume and target dose per administration. Most peptide suppliers ship Pinealon as lyophilised powder in 10mg vials, which means the actual number of usable doses is determined by how much bacteriostatic water you add and what concentration your protocol requires. Mix 10mg with 1mL bacteriostatic water and each 0.1mL injection delivers 1mg (1000mcg). Double the water to 2mL and the same 0.1mL now contains 500mcg. The calculation is straightforward once you understand the ratio. But the preparation step is where most errors occur.

Our team works with research-grade peptides daily at Real Peptides. We've found that reconstitution confusion. Not dosage math. Is the single biggest obstacle researchers face when handling lyophilised compounds like Pinealon.

How many doses are in a 10mg vial of Pinealon?

A 10mg Pinealon vial yields 10 doses at 1mg (1000mcg) per dose when reconstituted with 1mL bacteriostatic water, or 20 doses at 500mcg per dose when reconstituted with 2mL. The number of doses depends entirely on your target dose per administration and reconstitution volume. The vial contains a fixed 10mg total peptide mass that you divide according to protocol requirements.

Most researchers misunderstand Pinealon dosing as a pre-set number when it's actually a concentration calculation. The lyophilised powder contains 10mg of active peptide. Your reconstitution volume determines how concentrated each injection becomes. This article covers the exact reconstitution math, why bacteriostatic water volume matters more than injection volume, and what preparation mistakes destroy peptide integrity before the first dose.

Pinealon Vial Contents and Reconstitution Math

Pinealon is supplied as a lyophilised (freeze-dried) powder in sterile glass vials, typically containing 10mg of the active tetrapeptide sequence Glu-Asp-Arg-Pro. The vial itself contains no liquid. Reconstitution with bacteriostatic water is required before administration. Bacteriostatic water contains 0.9% benzyl alcohol as a preservative, allowing multi-dose use over 28 days when stored at 2–8°C. The most common error researchers make is assuming the vial comes pre-mixed or that "one vial equals one dose". Neither is correct.

The calculation works like this: if you add 1mL bacteriostatic water to a 10mg vial, the resulting concentration is 10mg/mL. Drawing 0.1mL (100 units on a standard insulin syringe) delivers 1mg. If you add 2mL instead, the concentration becomes 5mg/mL. The same 0.1mL draw now delivers 500mcg. Common protocols use 500mcg to 1000mcg per administration, meaning a single 10mg vial provides 10–20 doses depending on dilution ratio. Pre-clinical research published in Bulletin of Experimental Biology and Medicine used 100–500mcg dosing ranges in rodent models, extrapolating to human-equivalent doses in the same range.

Temperature control during reconstitution matters more than most researchers expect. Lyophilised peptides are stable at room temperature for short periods, but once reconstituted, the peptide is vulnerable to enzymatic degradation and oxidation. Add bacteriostatic water slowly down the side of the vial. Never inject directly onto the powder, which causes foaming and mechanical shear that denatures the peptide structure. Swirl gently to dissolve; do not shake. Our experience shows that 90% of "inactive peptide" complaints trace back to aggressive reconstitution technique or improper storage after mixing.

Pinealon Dose Calculation by Reconstitution Volume

The relationship between vial content, bacteriostatic water volume, and resulting dose per injection is purely mathematical. A 10mg vial reconstituted with different volumes yields these concentrations:

Most published Pinealon research uses 500mcg as a standard per-administration dose, which corresponds to 0.1mL from a 2mL reconstitution or 0.05mL from a 1mL reconstitution. Injection volume does not determine potency. Concentration does. Researchers often assume "more volume equals more peptide," but a 0.2mL injection from a 2mL reconstitution delivers the same 1mg as a 0.1mL injection from a 1mL reconstitution. The peptide mass is what matters; water is just the carrier.

Reconstitution volume also affects shelf life indirectly. Higher water volumes dilute the benzyl alcohol preservative, slightly reducing antimicrobial efficacy over the 28-day refrigerated storage window. The standard 1–2mL range keeps benzyl alcohol concentration effective without requiring excessive injection volumes. Peptides reconstituted beyond 3mL total volume should be used within 14 days rather than 28.

Storage and Stability After Reconstitution

Once reconstituted, Pinealon must be stored at 2–8°C (refrigerator temperature) and used within 28 days. The benzyl alcohol in bacteriostatic water prevents bacterial contamination during this period, but it does not prevent peptide degradation from oxidation or enzymatic breakdown. Temperature excursions above 8°C accelerate degradation exponentially. A vial left at room temperature for 24 hours loses measurable potency that neither visual inspection nor home testing can detect.

Lyophilised (unreconstituted) Pinealon should be stored at −20°C for long-term stability. At this temperature, the peptide remains stable for 12–24 months. Once opened and reconstituted, the 28-day clock starts immediately. Not when you draw the first dose. Mark the reconstitution date on the vial. If you're running a multi-week protocol and won't finish the vial within 28 days, reconstitute smaller batches or consider ordering multiple 5mg vials instead of one 10mg vial.

Travel and transport introduce the highest risk of temperature excursion. Unreconstituted vials can tolerate brief periods at room temperature (up to 25°C for 48 hours), but reconstituted peptides require continuous refrigeration. Insulin coolers that maintain 2–8°C for 36–48 hours without electricity are the standard solution for short trips. For longer travel, reconstitute a fresh vial at your destination rather than transporting a partially used one.

Pinealon Dose Comparison: Research Protocols

These ranges reflect published pre-clinical work and do not constitute dosing recommendations. Research dose selection depends on study design, species, and endpoint measurement. The table illustrates how reconstitution volume directly determines usable dose count from a fixed peptide mass.

What If: Pinealon Dosing Scenarios

What If I Accidentally Add Too Much Bacteriostatic Water?

The peptide remains usable. You've simply created a more dilute solution. Recalculate your dose volume to account for the new concentration. For example, if you added 3mL instead of 2mL to a 10mg vial, your concentration is now 3.33mg/mL instead of 5mg/mL. To deliver 500mcg, draw 0.15mL instead of 0.1mL. The total peptide mass in the vial hasn't changed. Only the volume per dose increases.

What If My Reconstituted Pinealon Looks Cloudy?

Cloudiness indicates contamination, particulate matter, or improper reconstitution technique. Pinealon should dissolve into a clear, colorless solution. Do not use cloudy or discolored peptide solutions. The structural integrity is compromised. Cloudiness often results from injecting water too forcefully onto the powder, creating foam and protein aggregation. Discard the vial and reconstitute a fresh one using slower, gentler technique.

What If I Miss the 28-Day Refrigerated Storage Window?

Potency degrades progressively after 28 days even under refrigeration. The benzyl alcohol preservative remains antimicrobially effective, but the peptide itself undergoes oxidative breakdown. Using peptide beyond 28 days post-reconstitution introduces dosing inconsistency. Early doses may deliver full potency while later doses deliver significantly less. For protocols requiring extended timelines, reconstitute smaller batches in sequence rather than one large batch at the start.

The Practical Truth About Pinealon Vial Yield

Here's the honest answer: most researchers overthink the "doses per vial" question when the real issue is reconstitution consistency. The vial contains 10mg of peptide. That's fixed. The variable is how you dilute it, and that decision should be driven by your protocol's target dose and injection frequency, not by trying to maximize dose count. A 10mg vial reconstituted with 2mL gives you 20 clean 500mcg doses with straightforward 0.1mL injections on a standard insulin syringe. Trying to stretch it further by adding 4mL just means drawing 0.2mL per dose. You haven't gained anything except injection volume.

The second mistake is treating the vial like a multi-month supply. Reconstituted peptides degrade. The 28-day window is a hard ceiling, not a suggestion. We've reviewed batch stability data across dozens of peptide compounds. Degradation curves after day 28 are steep and irreversible. If your protocol requires 15 doses over 8 weeks, order two 10mg vials and reconstitute the second one halfway through. The cost difference is negligible compared to the risk of administering degraded peptide in weeks 5–8.

For researchers committed to high-purity peptide tools, understanding reconstitution mechanics is non-negotiable. The difference between effective research and wasted time often comes down to whether the peptide was prepared and stored correctly. Not whether the study design was theoretically sound. Pinealon's tetrapeptide structure makes it relatively stable compared to longer-chain compounds, but stability is conditional on proper handling. Every research-grade peptide we supply at Real Peptides ships with reconstitution instructions because we've learned this is where protocols fail most often. Not at the dose calculation stage, but at the mixing stage.

Reconstitution determines dose yield, but technique determines whether those doses retain biological activity. Add water slowly, refrigerate immediately, use within 28 days, and mark every vial with the date mixed. These aren't optional steps. They're the baseline for reproducible results.